1. Home
  2. ASNS vs CLDI Comparison

ASNS vs CLDI Comparison

Compare ASNS & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actelis Networks Inc.

ASNS

Actelis Networks Inc.

HOLD

Current Price

$0.43

Market Cap

10.9M

ML Signal

HOLD

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

HOLD

Current Price

$1.11

Market Cap

9.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASNS
CLDI
Founded
1998
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9M
9.2M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
ASNS
CLDI
Price
$0.43
$1.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.9M
83.1K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,367,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$208.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$1.05
52 Week High
$16.90
$19.20

Technical Indicators

Market Signals
Indicator
ASNS
CLDI
Relative Strength Index (RSI) 30.29 33.77
Support Level $0.41 $1.05
Resistance Level $0.62 $1.16
Average True Range (ATR) 0.06 0.06
MACD 0.02 -0.00
Stochastic Oscillator 10.26 23.64

Price Performance

Historical Comparison
ASNS
CLDI

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The company operates as one operating segment: developing and marketing access broadband equipment for copper and fiber networks.

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

Share on Social Networks: